
It’s good to test your non-science skills every once in a while too. Happy to report the new upstairs floors are officially installed!

Postdoctoral Fellow in the Division of Cardiology at the University of Colorado Anschutz Medical Campus

It’s good to test your non-science skills every once in a while too. Happy to report the new upstairs floors are officially installed!

Had a great time at the @universityofky Saha Cardiovascular Research Center Research Day and very honored to have received the Gill Heart and Vascular Institute Early Contributions to Cardiovascular Research Award @GillKentucky



Congratulations @Robinson7L for winning the @ISHR_NAS Young Investigator Competition Award AND the Litsa G Kranias Leadership Award! Well deserved! Two years in a row for an @McKinseyLab member to win the YICA (@JoshTravers89 in 2022). Join our team to continue the tradition!

I'm delighted to share the Notice of Award for my K99 to further explore HDAC inhibition in diastolic dysfunction and HFpEF. Very grateful for the support from my advisory committee, @McKinseyLab, @CUAnschutz Division of Cardiology and @nih_nhlbi.

1/5 New @CircRes podcast #DiscoverCircRes (circresearch.libsyn.com)! @StHilaireLab chats with @McKinseyLab from @CUCardiology about their study Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart https://t.co/i6rv57n1hO

Rubino et al found that high-throughput #phenotypic screening with #fibroblasts yields a new molecular pathway for #fibrosis. Learn more about chemical screens for drug discovery for #HeartDisease at ahajrnls.org/3iqfMql @McKinseyLab @JoshTravers89 @CUCardiology


The @McKinseyLab has openings for motivated trainees to tackle how reversible PTMs regulate signaling and epigenetic pathways in cardiovascular and metabolic disease. We have a number of exciting projects which have the potential to launch many academic or industry careers.

We appreciate the opportunity to contribute an article on cardiac fibrosis for the @jclinicalinvest exciting review series on New Therapeutic Targets in Cardiovascular Diseases! @JoshTravers89 @CUAnschutz cfret.org jci.org/articles/view/148554

Today is #WorldHeartDay ♥️! Cardiovascular diseases including heart attacks and strokes are the leading cause of death globally, accounting for nearly 1⃣8⃣ million lives lost every year. Protect your heart 🫀 by choosing a healthy lifestyle 🏃🍊🚭 👉 https://t.co/afDLfGN0mT

Our work “A transcriptional switch governs fibroblast activation in heart disease” previously on @biorxivpreprint is now online @Nature. A great team effort @GladstoneInst @dsrivastava_md and all the fantastic collaborators. A new thread /1 👇 nature.com/articles/s41586-0…

I am looking for a motivated and enthusiastic research technician to join our lab and study how age and sex affects sarcomeric function in the heart❤️ cu.taleo.net/careersection/2…. Please RT☺️

Super excited to see our paper now out in this week’s issue @CircAHA! Thanks again to all involved. @JoshTravers89 Check out the accompanying podcast and editorial. ahajournals.org/doi/10.1161/… ahajournals.org/circ/podcast… cfret.org
HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling. Learn more here:ow.ly/hpaE50EK5xd #AHAJournals @rush6782 @sara_wennersten

HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling. Learn more here:ow.ly/hpaE50EK5xd #AHAJournals @rush6782 @sara_wennersten